Elevated levels, as proposed in obesity and evidenced by multiple animal studies, are likely, however, due to aberrant FGF21 signalling and an FGF21 resistant state [70, 75]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.